Navigation Links
Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011
Date:4/1/2011

GREENWOOD VILLAGE, Colo., April 1, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) ("Ampio") announced today that Mark D. McGregor will be appointed to the position of Chief Financial Officer and Corporate Secretary effective April 4, 2011. Mr. Bruce G. Miller, who served in these capacities since April 2010, will be joining the team that will advance the commercialization of Zertane, Ampio's product candidate that was the subject of a 2009 and 2010 Phase 3 multicenter clinical trial in Europe and was obtained through our acquisition of DMI BioSciences, Inc. Mr. Miller was with DMI BioSciences since 1992, having served as Chief Executive Officer and/or President throughout this period.

Mr. McGregor, a Certified Public Accountant, is a highly experienced financial executive with in-depth experience in treasury and risk management, including developing financial strategic plans, cash management and investments, managing foreign currency and interest rate exposures, credit provider and credit rating agency relations, and insurance risk management. His prior experience also encompasses:

  • corporate and international consolidation and reporting,
  • SEC and management reporting,
  • financial integration,
  • disbursements operations,
  • evaluating potential acquisitions,
  • conducting financial due diligence,
  • negotiating credit line provisions to promote operating flexibility,
  • optimizing capital structures, and
  • implementing stock buy-back programs to enhance stockholder value.

Mr. McGregor's career spans over 30 years of financial experience in a variety of industries. For 20 years he was with Storage Technology Corporation, a public international information and storage technology company with $2 billion in annual worldwide revenues, where he served in a variety of financial positions and advanced to Vice President, Corporate Treasurer and Corporate Development. Mr. McGregor was directly involved in two divestitures and four acquisitions while with Storage Technology Corporation, in addition to leading the deal team in connection with the sale of StorageTek to Sun Microsystems in 2005. He began his career with Price Waterhouse, now PricewaterhouseCoopers LLP, where he spent 13 years with the Audit Department.

About Ampio

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. The product pipeline includes new uses for previously approved drugs and new molecular entities ("NMEs"). By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near-term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs.

Forward-Looking Statements

Except for the historical information contained herein, this news release contains forward-looking statements that involve risk and uncertainties. The risks and uncertainties are detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Contact: Investor Relations
Ampio Pharmaceuticals, Inc:  303-418-1000
Redwood Consultants, LLC :  415-884-0348


'/>"/>
SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kaiser Permanente Recognized as a J.D. Power 2011 Customer Service Champion
2. CHAMPION Study Published in The Lancet
3. Champions CFO Resigns
4. Champions Biotechnology Awarded $1.46 million in Grants
5. Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His Notoriety in New ExtenZe Spots from Inter/Media Advertising
6. Dr. Brian Boxer Wachler to be Honored With Olympic Gold Medal Bobsled Champion Steve Holcomb Alongside Apple CEO Steve Jobs, James Cameron, Dan Rather, Quincy Jones and Others at 2010 Vision Awards in Beverly Hills
7. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
8. Ingrid Vandebosch, Wife of NASCAR Champion Jeff Gordon, Models Perfect Stance Against Pertussis Following Sons Birth
9. Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™
10. CardioMEMS Completes CHAMPION Clinical Trial Study
11. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
Breaking Medicine Technology:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):